Transport
Southwest Health Center, INC
Southwest Health Center, INC was paid $8.29M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 18% of everything it billed.
33Billing provider infoSOUTHWEST HEALTH CENTER, INC
PLATTEVILLE, WI 53818
PLATTEVILLE, WI 53818
33aNPI1831279793assigned 10/16/2006
33bProvider typeLand Ambulance
28Total paid$8.29M
24GClaims192,339
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Land Ambulance providers in Wisconsin
Rank by total paid#3 of 143
Median peer was paid$94K
This provider vs. median88×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,044 | $660K | |
| 2019 | 20,910 | $853K | |
| 2020 | 19,855 | $836K | |
| 2021 | 33,816 | $1.35M | |
| 2022 | 33,612 | $1.65M | |
| 2023 | 39,424 | $1.73M | |
| 2024incomplete | 28,678 | $1.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 18% | 5,297 | 2,843 | $1.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 7,113 | 4,698 | $1.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 7,287 | 5,339 | $984K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.5% | 5,038 | 4,045 | $704K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.5% | 8,224 | 5,670 | $536K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.4% | 6,091 | 4,547 | $450K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.2% | 2,539 | 1,490 | $435K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.9% | 880 | 793 | $240K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.3% | 7,415 | 2,261 | $188K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 2,176 | 1,202 | $173K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 4,379 | 3,759 | $163K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.9% | 522 | 230 | $155K |
161 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 751 | $152K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 701 | $142K |
| A0427 | Emergency ambulance ride, advanced life support | 1.1% | 868 | $92K |
| 80053 | Comprehensive metabolic panel | <1% | 8,455 | $73K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 527 | $66K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 334 | $65K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,884 | $58K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 734 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,482 | $49K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,957 | $49K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,560 | $48K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,543 | $47K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 152 | $47K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,543 | $46K |
| A0390 | Als mileage (per mile) | <1% | 551 | $31K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 212 | $31K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,759 | $30K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 359 | $27K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 835 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,114 | $26K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,021 | $23K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 310 | $23K |
| 80061 | Lipid panel | <1% | 1,952 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,850 | $22K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 344 | $20K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 315 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,610 | $17K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 186 | $17K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 724 | $17K |
| 87806 | <1% | 773 | $16K | |
| 81025 | <1% | 2,247 | $16K | |
| 87070 | <1% | 1,519 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,584 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,725 | $14K |
| 81001 | <1% | 5,178 | $14K | |
| G0378 | Hospital observation service, per hour | <1% | 1,022 | $13K |
| 97162 | <1% | 178 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 393 | $13K |
| 80050 | General health panel | <1% | 1,196 | $12K |
| 87430 | <1% | 799 | $12K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 316 | $11K |
| 84484 | <1% | 2,140 | $10K | |
| 85027 | <1% | 2,165 | $10K | |
| 80306 | <1% | 674 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 60 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 717 | $8K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 58 | $8K |
| 83690 | <1% | 1,866 | $7K | |
| 93356 | <1% | 29 | $7K | |
| 92567 | <1% | 238 | $7K | |
| 59025 | Fetal non-stress test | <1% | 42 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,238 | $7K |
| 87506 | <1% | 35 | $6K | |
| 87186 | <1% | 1,014 | $6K | |
| 88142 | <1% | 329 | $5K | |
| 73630 | <1% | 199 | $5K | |
| 0011A | <1% | 199 | $5K | |
| 86803 | <1% | 416 | $5K | |
| 73610 | <1% | 168 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 58 | $4K |
| 83605 | <1% | 838 | $4K | |
| 83880 | <1% | 337 | $4K | |
| 0012A | <1% | 167 | $4K | |
| 81003 | <1% | 1,625 | $4K | |
| 86140 | <1% | 1,207 | $4K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 15 | $4K |
| 80305 | <1% | 412 | $3K | |
| 82962 | <1% | 1,698 | $3K | |
| 82947 | <1% | 750 | $3K | |
| 86850 | <1% | 679 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,400 | $3K |
| 82728 | <1% | 257 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 179 | $3K |
| 87905 | <1% | 271 | $3K | |
| 87507 | <1% | 13 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 60 | $3K |
| A0380 | Bls mileage (per mile) | <1% | 40 | $3K |
| 82565 | <1% | 643 | $2K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 54 | $2K |
| 73110 | <1% | 65 | $2K | |
| 82077 | <1% | 269 | $2K | |
| 84460 | <1% | 575 | $2K | |
| 86780 | <1% | 217 | $2K | |
| 84450 | <1% | 547 | $2K | |
| 87808 | <1% | 149 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,371 | $2K |
| 82607 | <1% | 154 | $2K | |
| 84466 | <1% | 216 | $2K | |
| 83540 | <1% | 385 | $2K | |
| 82746 | <1% | 153 | $2K | |
| 82247 | <1% | 523 | $2K | |
| 85610 | <1% | 404 | $2K | |
| 82310 | <1% | 488 | $2K | |
| 73030 | <1% | 67 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $2K |
| 84075 | <1% | 488 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 37 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 196 | $2K |
| 82040 | <1% | 487 | $2K | |
| 83735 | <1% | 507 | $2K | |
| 84132 | <1% | 500 | $2K | |
| 73502 | <1% | 67 | $2K | |
| 82374 | <1% | 479 | $2K | |
| 84295 | <1% | 480 | $2K | |
| 82435 | <1% | 479 | $1K | |
| 87486 | <1% | 58 | $1K | |
| 74019 | <1% | 46 | $1K | |
| 87210 | <1% | 225 | $1K | |
| 85379 | <1% | 214 | $1K | |
| 87581 | <1% | 58 | $1K | |
| 84520 | <1% | 481 | $1K | |
| 84155 | <1% | 481 | $1K | |
| 73562 | <1% | 58 | $1K | |
| 86900 | <1% | 564 | $1K | |
| 86901 | <1% | 559 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 47 | $1K |
| A0425 | Ground mileage, per statute mile | <1% | 832 | $946.04 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,341 | $920.67 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 37 | $811.71 |
| 74018 | <1% | 25 | $666.52 | |
| 0064A | <1% | 48 | $659.68 | |
| 73130 | <1% | 34 | $594.87 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $585.87 |
| 86762 | <1% | 27 | $567.29 | |
| 87340 | <1% | 72 | $544.17 | |
| 83718 | <1% | 75 | $501.58 | |
| 84439 | <1% | 64 | $456.43 | |
| 73564 | <1% | 18 | $391.91 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 22 | $380.56 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 342 | $337.05 |
| 72100 | <1% | 17 | $316.96 | |
| 87077 | <1% | 43 | $277.07 | |
| 97116 | <1% | 32 | $193.38 | |
| 71045 | Radiologic examination, chest; single view | <1% | 766 | $178.79 |
| 82043 | <1% | 28 | $146.93 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 562 | $134.05 |
| 87088 | <1% | 13 | $91.96 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,819 | $77.30 |
| 87040 | <1% | 17 | $63.96 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,033 | $50.04 |
| 85651 | <1% | 13 | $36.09 | |
| 93000 | <1% | 14 | $35.89 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,971 | $35.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,645 | $18.59 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,876 | $14.66 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,236 | $5.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,030 | $5.62 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 156 | $3.11 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 67 | $2.84 |
| 96376 | <1% | 234 | $0.29 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 84 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 115 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 134 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 79 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 163 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 42 | $0.00 |
| 91301 | 0% | 107 | $0.00 | |
| 91306 | 0% | 15 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 54 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 19 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOOKOCHOFF, JESSE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Southwest Health Center, INC. | Platteville, WI | $2.29M |
| Southwest Health Center, INC. | Platteville, WI | $34K |
| Southwest Health Center, INC. | Kieler, WI | $27K |
| Southwest Health Center, INC. | Lancaster, WI | $21K |
| Southwest Health Center, INC. | Darlington, WI | $13K |
| Southwest Health Center, INC | Kieler, WI | $4K |
| Southwest Health Center INC | Platteville, WI | $340.20 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.